🎉 M&A multiples are live!
Check it out!

Claritev Valuation Multiples

Discover revenue and EBITDA valuation multiples for Claritev and similar public comparables like Proteomics International, Beamtree, and Cogstate.

Claritev Overview

About Claritev

Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.


Founded

2019

HQ

United States of America
Employees

2.7K+

Website

claritev.com

Financials

LTM Revenue $928M

LTM EBITDA $577M

EV

$5.2B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 12K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Claritev Financials

Claritev has a last 12-month revenue (LTM) of $928M and a last 12-month EBITDA of $577M.

In the most recent fiscal year, Claritev achieved revenue of $931M and an EBITDA of -$1.0B.

Claritev expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Claritev valuation multiples based on analyst estimates

Claritev P&L

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue $928M XXX $931M XXX XXX XXX
Gross Profit $687M XXX $691M XXX XXX XXX
Gross Margin 74% XXX 74% XXX XXX XXX
EBITDA $577M XXX -$1.0B XXX XXX XXX
EBITDA Margin 62% XXX -108% XXX XXX XXX
EBIT -$787M XXX $98.9M XXX XXX XXX
EBIT Margin -85% XXX 11% XXX XXX XXX
Net Profit -$1.1B XXX -$1.6B XXX XXX XXX
Net Margin -115% XXX -177% XXX XXX XXX
Net Debt XXX XXX $4.5B XXX XXX XXX

Financial data powered by Morningstar, Inc.

Claritev Stock Performance

As of May 30, 2025, Claritev's stock price is $38.

Claritev has current market cap of $632M, and EV of $5.2B.

See Claritev trading valuation data

Claritev Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$5.2B $632M XXX XXX XXX XXX $-65.93

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Claritev Valuation Multiples

As of May 30, 2025, Claritev has market cap of $632M and EV of $5.2B.

Claritev's trades at 5.6x EV/Revenue multiple, and -5.2x EV/EBITDA.

Equity research analysts estimate Claritev's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

Claritev has a P/E ratio of -0.6x.

See valuation multiples for Claritev and 12K+ public comps

Claritev Financial Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $632M XXX $632M XXX XXX XXX
EV (current) $5.2B XXX $5.2B XXX XXX XXX
EV/Revenue 5.6x XXX 5.6x XXX XXX XXX
EV/EBITDA 9.1x XXX -5.2x XXX XXX XXX
EV/EBIT -6.7x XXX 53.0x XXX XXX XXX
EV/Gross Profit 7.6x XXX n/a XXX XXX XXX
P/E -0.6x XXX -0.4x XXX XXX XXX
EV/FCF -81.7x XXX -498.8x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Claritev Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Claritev Margins & Growth Rates

Claritev's last 12 month revenue growth is 1%

Claritev's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.

Claritev's rule of 40 is 69% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Claritev's rule of X is 65% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Claritev and other 12K+ public comps

Claritev Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth 1% XXX 2% XXX XXX XXX
EBITDA Margin 62% XXX -108% XXX XXX XXX
EBITDA Growth 2% XXX -6% XXX XXX XXX
Rule of 40 69% XXX -107% XXX XXX XXX
Bessemer Rule of X XXX XXX 65% XXX XXX XXX
Revenue per Employee XXX XXX $0.3M XXX XXX XXX
Opex per Employee XXX XXX $0.2M XXX XXX XXX
S&M Expenses to Revenue XXX XXX n/a XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX n/a XXX XXX XXX
Opex to Revenue XXX XXX 64% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Claritev Public Comps

See public comps and valuation multiples for Health Data & Analytics and Revenue Cycle Management comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Beamtree XXX XXX XXX XXX XXX XXX
Cogstate XXX XXX XXX XXX XXX XXX
Echo IQ XXX XXX XXX XXX XXX XXX
Impedimed XXX XXX XXX XXX XXX XXX
Proteomics International XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Claritev M&A and Investment Activity

Claritev acquired  XXX companies to date.

Last acquisition by Claritev was  XXXXXXXX, XXXXX XXXXX XXXXXX . Claritev acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Claritev

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Start Free Trial

About Claritev

When was Claritev founded? Claritev was founded in 2019.
Where is Claritev headquartered? Claritev is headquartered in United States of America.
How many employees does Claritev have? As of today, Claritev has 2.7K+ employees.
Who is the CEO of Claritev? Claritev's CEO is Mr. Travis S. Dalton.
Is Claritev publicy listed? Yes, Claritev is a public company listed on NYS.
What is the stock symbol of Claritev? Claritev trades under CTEV ticker.
When did Claritev go public? Claritev went public in 2020.
Who are competitors of Claritev? Similar companies to Claritev include e.g. Beamtree, Cogstate, Echo IQ, Impedimed.
What is the current market cap of Claritev? Claritev's current market cap is $632M
What is the current revenue of Claritev? Claritev's last 12 months revenue is $928M.
What is the current revenue growth of Claritev? Claritev revenue growth (NTM/LTM) is 1%.
What is the current EV/Revenue multiple of Claritev? Current revenue multiple of Claritev is 5.6x.
Is Claritev profitable? Yes, Claritev is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Claritev? Claritev's last 12 months EBITDA is $577M.
What is Claritev's EBITDA margin? Claritev's last 12 months EBITDA margin is 62%.
What is the current EV/EBITDA multiple of Claritev? Current EBITDA multiple of Claritev is 9.1x.
What is the current FCF of Claritev? Claritev's last 12 months FCF is -$64.1M.
What is Claritev's FCF margin? Claritev's last 12 months FCF margin is -7%.
What is the current EV/FCF multiple of Claritev? Current FCF multiple of Claritev is -81.7x.

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.